Editorial Journal of the American College of Cardiology. 2025 Jun 17;85(23):2267-2269. doi: 10.1016/j.jacc.2025.04.017 Q121.72024

Kansas City Cardiomyopathy Questionnaire: A Measure of Heart-Failure Risk, But Can it Improve Outcomes?

堪萨斯城心肌病问卷：评估心力衰竭风险的工具，但能否改善预后？ 翻译改进

作者单位 +展开

DOI: 10.1016/j.jacc.2025.04.017 PMID: 40499981

摘要 中英对照阅读

Copyright © Journal of the American College of Cardiology. 中文内容为AI机器翻译，仅供参考！

相关内容

• Association of Systemic Thromboxane Generation With Risk of Developing Heart Failure

  血小板生成剂的全身性产生与心力衰竭发病风险的相关性研究

  Jeffrey J Rade et al.

  Journal of the American College of Cardiology. 2025 Jan 7;85(1):58-70.

• Electrocardiographic left atrial abnormality and risk of heart failure

  心电图左房异常和心力衰竭风险的关系

  Sunnie Li et al.

  Journal of electrocardiology. 2024 Jan-Feb:82:7-10.

• Is high-dose intravenous fosfomycin safe for the treatment of patients prone to heart failure?

  高剂量注射磷霉素用于易患心力衰竭患者的治疗安全吗？

  Irene Cañamares-Orbis et al.

  Enfermedades infecciosas y microbiologia clinica. 2015 Apr;33(4):294.

• Plasma phospholipid saturated fatty acids and heart failure risk in the Physicians' Health Study

  医师健康研究中的磷脂饱和脂肪酸与心力衰竭风险的关系

  Chisa Matsumoto et al.

  Clinical nutrition (Edinburgh, Scotland). 2013 Oct;32(5):819-23.

• The Safety of Dipeptidyl Peptidase 4 Inhibitors and the Risk for Heart Failure

  二肽基肽酶抑制剂的安全性与心力衰竭风险的关系

  Benjamin M Scirica

  JAMA cardiology. 2016 May 1;1(2):123-5.

• Do dipeptidyl peptidase-4 inhibitors increase the risk of heart failure?

  二肽基肽酶-4抑制剂增加心力衰竭风险吗？

  Deepak L Bhatt

  JACC. Heart failure. 2014 Dec;2(6):583-5.

• NSAID erhöhen das Risiko einer Herzinsuffizienz unterschiedlich stark

  非甾体抗炎药加重心力衰竭的风险不同

  Johann Steurer

  Praxis. 2016;105(25):1507-1508.

• Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure Risk

  美国食品药品监督管理部门就心力衰竭风险发出警告背景下二肽基肽酶-4抑制剂的当代应用趋势分析

  Muthiah Vaduganathan et al.

  The American journal of cardiology. 2020 May 15;125(10):1577-1581.

• Predictors of Major Atrial Fibrillation Endpoints in the National Heart, Lung, and Blood Institute HCMR

  国家心脏、肺和血液研究所HCM风险评估中的房颤主要终点事件的预测因素

  Christopher M Kramer et al.

  JACC. Clinical electrophysiology. 2021 Nov;7(11):1376-1386.